Trending News

A study warns that rodent populations are developing genetic resistance to standard poisons. This shift complicates urban pest control and may force a rethink of current chemical-based strategies.

A surge in venture capital is driving a new gold rush in peptide manufacturing, as startups race to scale synthetic production despite significant regulatory and safety questions.

A new at-home diagnostic kit claims to identify Lyme disease pathogens in 15 minutes, but experts and testers are questioning its reliability compared to professional lab standards.

Biotech deal-making is experiencing a resurgence not seen since 2019, as large pharmaceutical firms scramble to fill pipeline gaps through aggressive acquisitions.

Claims of a DIY Alzheimer's cure developed in a basement have emerged online, yet the report lacks the clinical data or institutional backing required to validate its scientific legitimacy.

Did Ozempic happen by accident? An analysis suggests the 'silly' discovery narrative ignores the decades of metabolic research that made the drug possible.